Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

T. E. van Mens; H. R. Büller; M. Nieuwdorp

doi:10.1111/jth.14331

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

T. E. van Mens, H. R. Büller, M. Nieuwdorp

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	3-5
Journal	Journal of thrombosis and haemostasis
Volume	17
Issue number	1
Early online date	2018
DOIs	https://doi.org/10.1111/jth.14331
Publication status	Published - 2019

Access to Document

10.1111/jth.14331

Cite this

@article{53237b2efe1f46bca466174fea4cfc5a,

title = "Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?",

author = "{van Mens}, {T. E.} and B{\"u}ller, {H. R.} and M. Nieuwdorp",

year = "2019",

doi = "10.1111/jth.14331",

language = "English",

volume = "17",

pages = "3--5",

journal = "Journal of thrombosis and haemostasis",

issn = "1538-7933",

publisher = "Wiley Blackwell",

number = "1",

}

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease? / van Mens, T. E.; Büller, H. R.; Nieuwdorp, M.
In: Journal of thrombosis and haemostasis, Vol. 17, No. 1, 2019, p. 3-5.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

AU - van Mens, T. E.

AU - Büller, H. R.

AU - Nieuwdorp, M.

PY - 2019

Y1 - 2019

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85058079021&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30548165

U2 - 10.1111/jth.14331

DO - 10.1111/jth.14331

M3 - Article

C2 - 30548165

SN - 1538-7933

VL - 17

SP - 3

EP - 5

JO - Journal of thrombosis and haemostasis

JF - Journal of thrombosis and haemostasis

IS - 1

ER -

Targeted inhibition of gut microbiota proteins involved in TMAO production to reduce platelet aggregation and arterial thrombosis: a blueprint for drugging the microbiota in the treatment of cardiometabolic disease?

Access to Document

Other files and links

Cite this